Gonococcal cystitis and urethritis, unspecified
ICD-10 A54.01 is a billable code used to indicate a diagnosis of gonococcal cystitis and urethritis, unspecified.
Gonococcal cystitis and urethritis, unspecified, refers to an infection of the bladder (cystitis) and urethra caused by the Neisseria gonorrhoeae bacterium, which is a sexually transmitted infection (STI). This condition is characterized by inflammation of the urinary tract, leading to symptoms such as dysuria (painful urination), increased urinary frequency, and urgency. In some cases, patients may also experience purulent discharge from the urethra. Gonococcal infections can lead to serious complications if left untreated, including pelvic inflammatory disease in women and epididymitis in men. The unspecified designation indicates that the specific manifestations or severity of the infection have not been detailed. Diagnosis typically involves laboratory testing, including nucleic acid amplification tests (NAATs) or culture methods. Treatment usually consists of antibiotic therapy, with the Centers for Disease Control and Prevention (CDC) recommending dual therapy with ceftriaxone and azithromycin to effectively combat the infection and prevent antibiotic resistance.
Detailed patient history, including sexual practices, and results of urinalysis and cultures.
Patients presenting with dysuria, urinary frequency, and urethral discharge.
Consideration of potential complications such as epididymitis or prostatitis.
Comprehensive documentation of STI screening and treatment plans.
Patients with multiple STIs or recurrent gonococcal infections.
Need for contact tracing and partner notification.
Used when testing for gonorrhea in symptomatic patients.
Document the reason for testing and patient symptoms.
Urology and Infectious Disease specialists should ensure accurate test ordering.
Common symptoms include dysuria, increased urinary frequency, urgency, and purulent discharge from the urethra.
Diagnosis is typically made through laboratory testing, including nucleic acid amplification tests (NAATs) or cultures.
The CDC recommends dual therapy with ceftriaxone and azithromycin to effectively treat gonococcal infections.
